Literature DB >> 11312348

Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function.

G W Schatz1, J Reinking, J Zippin, L K Nicholson, V M Vogt.   

Abstract

All retrovirus proteases (PRs) are homodimers, and dimerization is essential for enzymatic function. The dimer is held together largely by a short four-stranded antiparallel beta sheet composed of the four or five N-terminal amino acid residues and a similar stretch of residues from the C terminus. We have found that the enzymatic and structural properties of Rous sarcoma virus (RSV) PR are exquisitely sensitive to mutations at the N terminus. Deletion of one or three residues, addition of one residue, or substitution of alanine for the N-terminal leucine reduced enzymatic activity on peptide and protein substrates 100- to 1,000-fold. The purified mutant proteins remained monomeric up to a concentration of about 2 mg/ml, as determined by dynamic light scattering. At higher concentrations, dimerization was observed, but the dimer lacked or was deficient in enzymatic activity and thus was inferred to be structurally distinct from a wild-type dimer. The mutant protein lacking three N-terminal residues (DeltaLAM), a form of PR occurring naturally in virions, was examined by nuclear magnetic resonance spectroscopy and found to be folded at concentrations where it was monomeric. This result stands in contrast to the report that a similarly engineered monomeric PR of human immunodeficiency virus type 1 is unstructured. Heteronuclear single quantum coherence spectra of the mutant at concentrations where either monomers or dimers prevail were nearly identical. However, these spectra differed from that of the dimeric wild-type RSV PR. These results imply that the chemical environment of many of the amide protons differed and thus that the three-dimensional structure of the DeltaLAM PR mutant is different from that of the wild-type PR. The structure of this mutant protein may serve as a model for the structure of the PR domain of the Gag polyprotein and may thus give clues to the initiation of proteolytic maturation in retroviruses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312348      PMCID: PMC114231          DOI: 10.1128/JVI.75.10.4761-4770.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Autoprocessing of HIV-1 protease is tightly coupled to protein folding.

Authors:  J M Louis; G M Clore; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1999-09

2.  Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.

Authors:  S M Joshi; V M Vogt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Properties of avian retrovirus particles defective in viral protease.

Authors:  L Stewart; G Schatz; V M Vogt
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease.

Authors:  C L DiIanni; L J Davis; M K Holloway; W K Herber; P L Darke; N E Kohl; R A Dixon
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

5.  Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.

Authors:  K Strisovsky; U Tessmer; J Langner; J Konvalinka; H G Kräusslich
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

6.  Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates.

Authors:  M Kotler; W Danho; R A Katz; J Leis; A M Skalka
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

7.  Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution.

Authors:  M Jaskólski; M Miller; J K Rao; J Leis; A Wlodawer
Journal:  Biochemistry       Date:  1990-06-26       Impact factor: 3.162

8.  Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases.

Authors:  I T Weber
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  1H, 15N and 13C assignments of a monomeric N-terminal deletion mutant of the Rous sarcoma virus protease.

Authors:  J L Reinking; G W Schatz; V M Vogt; L K Nicholson
Journal:  J Biomol NMR       Date:  2001-03       Impact factor: 2.835

10.  Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid.

Authors:  P H Hirel; M J Schmitter; P Dessen; G Fayat; S Blanquet
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more
  4 in total

1.  A molecular switch required for retrovirus assembly participates in the hexagonal immature lattice.

Authors:  Judith M Phillips; Paul S Murray; Diana Murray; Volker M Vogt
Journal:  EMBO J       Date:  2008-04-10       Impact factor: 11.598

2.  Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.

Authors:  Marek Ingr; Tat'ána Uhlíková; Kvido Strísovský; Eva Majerová; Jan Konvalinka
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

3.  The Structure of Immature Virus-Like Rous Sarcoma Virus Gag Particles Reveals a Structural Role for the p10 Domain in Assembly.

Authors:  Florian K M Schur; Robert A Dick; Wim J H Hagen; Volker M Vogt; John A G Briggs
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

4.  Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism.

Authors:  Steven C Pettit; Lorraine E Everitt; Sumana Choudhury; Ben M Dunn; Andrew H Kaplan
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.